This assignment delves into the potential adverse effects of herbal medicines, referencing systematic reviews and clinical findings. It also examines relevant UK healthcare policies regarding cancer research and treatment, as well as broader health policies implemented under the coalition government. The document further analyzes the impact of cost-effectiveness ratios on funding decisions for cancer drugs within the NHS.